CHOLECYSTECTOMY WITH INTRAOPERATIVE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY: DOES THE ORDER MATTER?
João de Bona Castelan, Arthur Pizzolatti Zapelini, Felipe Antônio Cacciatori, Bruno Zilberstein

TL;DR
This study examines whether the order of cholecystectomy and ERCP affects outcomes in treating gallstones and bile duct stones.
Contribution
It is the first to analyze the impact of procedure order on success rates and complications in a single surgical session.
Findings
Performing ERCP first was associated with higher success in bile duct cannulation.
Lymphopenia and cholecystitis were linked to failure in clearing the bile duct.
Procedure order did not significantly affect overall complications or bile duct clearance success.
Abstract
The recommended treatment for cholecystocholedocholithiasis is cholecystectomy (CCT) associated with endoscopic retrograde cholangiopancreatography (ERCP). CCT with intraoperative ERCP is associated with higher success rates and lower hospital stays and hospital costs. However, some case series do not describe the exact methodology used: whether ERCP or CCT was performed first. Verify if there is a difference, in terms of outcomes and complications, when intraoperative ERCP is performed immediately before or after CCT. This is a retrospective case-control study analyzing all patients who underwent CCT with intraoperative ERCP between January 2021 and June 2022, in a tertiary hospital in southern Brazil, for the treatment of cholecystocholedocholithiasis. Out of 37 patients analyzed, 16 (43.2%) underwent ERCP first, immediately followed by CCT. The overall success rate for the…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Characteristics | n=37 | |
|---|---|---|
| Age (years) | 46.5±23.5 | |
| Gender | ||
| Male | 11 (29.7) | |
| Female | 26 (70.3) | |
| BMI | 27.8±4.7 | |
| Axillary temperature | 36.2±0.4 | |
| Hematocrit | 39.2±7.3 | |
| Amylase at arrival | 68.0 (53.5–130.0) | |
| Leukocytes at arrival | 9588.6±4476.5 | |
| Lymphocytes at arrival | 1740.3±1066.3 | |
| Total bilirubin at arrival | 4.6 (1.25–9.95) | |
| Number of stones at the MR | 2 (1.0–4.0) | |
| Size of the largest stone (millimeters) | 5.9±3.5 | |
| Stones in the distal common bile duct? | ||
| Yes | 15 (40.5) | |
| No | 22 (59.5) | |
| Cholecystitis as initial presentation? | ||
| Yes | 5 (13.5) | |
| No | 32 (86.5) | |
| Acute pancreatitis as initial presentation? | ||
| Yes | 5 (13.5) | |
| No | 32 (86.5) | |
| Interval between admission and procedure (days) | 6.6±4.9 | |
| Order of procedures | ||
| ERCP followed by cholecystectomy | 16 (43.2) | |
| Cholecystectomy followed by ERCP | 21 (56.8) | |
| Success in the cannulation of the bile duct? | ||
| Yes | 34 (91.9) | |
| No | 3 (8.1) | |
| Success in clearing the bile duct? | ||
| Yes | 28 (75.7) | |
| No | 9 (24.3) | |
| Papillotomy? | ||
| Yes | 35 (94.6) | |
| No | 2 (5.4) | |
| Total duration of the procedure (minutes) | 178.9±66.1 | |
| Number of stones removed | 1 (0.0–2.0) | |
| Sugrue | ||
| A) Easy | 18 (48.6) | |
| B) Moderate | 14 (37.8) | |
| C) Hard | 5 (13.5) | |
| Post-ERCP amylase | 94.0 (58.0–306.0) | |
| Days admitted after procedure | 1.0 (1.0–2.0) | |
| General complications after procedure | ||
| Post-ERCP pancreatitis | 4 (10.8) | |
| Asymptomatic hyperamylasemia | 3 (8.1) | |
| Coleperioneum | 1 (2.7) | |
| Complications greater than Clavien-Dindo II | 1 (2.7) | |
| Variables | ERCP firstn=16 | CCT firstn=21 | p-value | ||
|---|---|---|---|---|---|
| Age (years) | 38.0±18.1 | 45.0±27.0 | 0.914 | ||
| Gender | |||||
| Male | 3 (18.8) | 8 (38.1) | 0.195 | ||
| Female | 13 (81.3) | 13 (61.9) | |||
| BMI | 28.5±5.0 | 28.3±5.1 | 0.945 | ||
| Amylase at arrival | 55.0 (48.2–66.7) | 92 (68.7–273.0) | 0.008 | ||
| Leukocytes at arrival | 9,666.7±4124.7 | 8739.6±3228.1 | 0.091 | ||
| Lymphocytes at arrival | 1,970.1±1487.9 | 1548.6±834.2 | 0.629 | ||
| Total bilirubin at arrival | 6.1 (1.9–9.5) | 3.5 (1.2–4.6) | 0.027 | ||
| Number of stones in the common bile duct | 1.0 (1.0–6.0) | 2.0 (1.0–4.0) | 0.534 | ||
| Success in cannulation? | |||||
| Yes | 13 (81.3) | 21 (100.0)a | 0.020 | ||
| No | 3 (18.8) | 0 (0.0) | |||
| Success in clearing the bile duct? | |||||
| Yes | 12 (75.0) | 16 (76.2) | 0.933 | ||
| No | 4 (25.0) | 5 (23.8) | |||
| Post-ERCP pancreatitis? | |||||
| Yes | 1 (6.3) | 3 (14.3) | 0.423 | ||
| No | 15 (93.8) | 18 (85.7) | |||
| Sugrue et al.37 | |||||
| A | 6 (37.5) | 12 (57.1) | 0.458 | ||
| B | 7 (43.8) | 7 (33.3) | |||
| C | 3 (18.8) | 2 (9.5) | |||
| Variables | Success in clearingn=28 | Without success in clearingn=9 | p-value | ||
|---|---|---|---|---|---|
| Age (years) | 35.3±19.4 | 61.8±24.6 | 0.073 | ||
| Gender | |||||
| Male | 9 (32.1) | 2 (22.2) | 0.563 | ||
| Female | 19 (67.9) | 7 (77.8) | |||
| BMI | 28.5±5.3 | 28.0±4.2 | 0.665 | ||
| Amylase when admitted | 77 (58.5–410.0) | 66 (42.0–92.0) | 0.101 | ||
| Leukocytes when admitted | 8066.9 ± 2817.2 | 12347.1 ± 3967.2 | 0.137 | ||
| Lymphocytes when admitted | 2027.2±1162.8 | 835.4±501.9 | 0.004 | ||
| Total bilirubin at arrival | 4.3 (1.4–6.1) | 4.6 (1.2–7.6) | 0.599 | ||
| Number of stones in the common bile duct | 1 (1.0–3.5) | 2 (1.0–10.0) | 0.392 | ||
| Size of the larges stones in mm | 5.2±3.2 | 6.2±3.7 | 0.410 | ||
| Duration of Procedure in min | 166.0±60.8 | 241.0±78.9 | 0.011 | ||
| Post-ERCP Amylase | 78.0 (58.0–156.5) | 402.0 (80.0–438.0) | 0.396 | ||
| Stones in the distal common bile duct? | |||||
| Yes | 14 (50.0) | 1 (11.1) | 0.027 | ||
| No | 14 (50.0) | 8 (88.9) | |||
| Cholecistitis as initial presentation? | |||||
| Yes | 1 (3.6) | 4 (44.4) | 0.004 | ||
| No | 27 (96.4) | 5 (55.6) | |||
| Pancreatitis as initial presentation? | |||||
| Yes | 5 (17.9) | 0 (0.0) | 0.082 | ||
| No | 23 (82.1) | 9 (100) | |||
| Post-ERCP pancreatitis? | |||||
| Yes | 4 (14.3) | 0 (0.0) | 0.123 | ||
| No | 24 (85.7) | 9 (100.0) | |||
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGallbladder and Bile Duct Disorders · Pancreatic and Hepatic Oncology Research · Cholangiocarcinoma and Gallbladder Cancer Studies
INTRODUCTION
The treatment of cholelithiasis with choledocholithiasis is complex and can be performed by cholecystectomy (CCT) with choledochotomy^ 27 ^, either laparoscopically or open, or by CCT combined with endoscopic approach of the bile duct, using endoscopic retrograde cholangiopancreatography (ERCP)^ 15,25,29 ^. However, the ideal time to perform CCT, before^ 16 ^, during^ 14,18 ^ or after^ 30,31 ^ ERCP, is a controversial topic and is still under discussion in the literature^ 2,15,17,20,28,29,40 ^.
Performing intraoperative ERCP with CCT for timely treatment of cholelithiasis with choledocholithiasis is associated with higher rates of success, shorter hospital stays and lower hospital costs^ 8,18,20,21,28,33,40 ^. This indication, however, is limited to services in which the surgeon is qualified to perform both procedures or in which there is availability of an endoscopist to perform the procedure at the surgical center together with CCT^ 1,22 ^.
Some published case series on the topic mention the CCT being performed first, under general anesthesia, followed immediately by ERCP^ 14,18 ^. Others performed ERCP first, followed by CCT^ 21,28 ^. There are also series that use the laparoscopic rendezvous technique for intraoperative ERCP^ 10,26,32 ^. However, some of the series found do not describe the exact methodology^ 12,20,23,33 ^.
The objective of the present study is to verify whether or not there are differences in terms of outcomes and complications when ERCP is performed immediately before or after CCT, but in the same surgical/anesthetic procedure, in order to clarify this gap in the literature.
METHODS
Retrospective case-control study, analyzing all patients who underwent CCT with ERCP in the same surgical/anesthetic procedure, between January 2021 and June 2022, in a tertiary general hospital in southern Brazil, in a total of 37 cases. The exclusion criteria, which were incomplete medical records and age under 18, did not discard any records. All patients had a preoperative diagnosis confirmed by magnetic cholangioresonance imaging of choledocholithiasis with cholelithiasis.
The hospital serves a population of around one million inhabitants, being a reference for patients with choledocholithiasis and receiving patients referred from other institutions or treated urgently. The hypothesis of choledocholithiasis is made during medical history and physical examination and confirmed by initial complementary tests, such as serum levels of bilirubin, amylase and canalicular enzymes, in addition to ultrasound^ 7,41 ^. Given this clinical picture, a specific investigation of the bile ducts is indicated, using magnetic cholangioresonance^ 41 ^.
Once the diagnosis of choledocholithiasis with cholelithiasis has been confirmed, the definitive treatment is determined through ERCP with CCT in the same surgical/anesthetic act, both procedures being performed by the same surgeon. In the operating room, after general anesthesia, the patient is positioned in the left lateral decubitus position and the first ERCP is performed and then repositioned to supine position to perform videolaparoscopic CCT surgery, or vice versa, with no clear reason to indicate one procedure or the other to be performed first. Prophylactic measures for post-ERCP pancreatitis are not used in the institution, such as vigorous hydration^ 5,38 ^, rectal indomethacin^ 6,33,35,36 ^, or any other methods^ 11 ^. Serum amylase is routinely dosed 6 hours later, to identify complications associated with the procedure.
The electronic medical records were retrospectively analyzed and the data tabulated comparing the variables and outcomes of patients allocated in the "ERCP first" or "CCT first" groups. Afterwards, patients were reallocated into the "Success in bile duct clearance" or "Without success in bile duct clearance" groups, in order to detail the findings of the casuistry. Data tabulation took place in Microsoft Excel software and statistical analysis was performed using IBM Statistical Package for the Social Sciences (SPSS) Statistics, version 18.0 of the software, through the construction of frequency distributions and comparisons between the dependent and independent variables. As measures of central tendency the measurements of averages and standard deviation were used, as well as the median and interquartile range. The Kolmogorov-Smirnov test was used to determine the normality or non-normality of comparative data, and Student's t or Mann-Whitney's U tests were used for the other analysis. Pearson's chi-square and likelihood ratio, with complementary evaluation of the analysis of residue and Cramer's V test were used. The definition employed for successful bile duct cannulation was the effective passage of the guidewire through the duodenal papilla with radioscopic confirmation of the bile duct catheterization.
The definition used for successfully clearing the bile duct was the absence of radioscopic images that could suggest the continuance of stones after appropriate procedures. The duration of the procedure was recorded from the time of beginning anesthetic induction, therefore including the airway management time for the anesthesiologist. The end of the procedure was the patient's extubation, which was successful in all cases analyzed. The definition used for post-ERCP pancreatitis is the occurrence of new epigastric pain associated with an increase in pancreatic enzymes three times higher than the regular upper limit, within 24 hours of the procedure, and requiring hospitalization for more than two nights^ 11,39,40 ^. When the occurrence of isolated hyperamylasemia was identified without clinical alterations or need to remain hospitalized, the condition was defined as asymptomatic hyperamylasemia^ 9 ^.
The study was approved by the institution's Ethics Committee, duly registered on Plataforma Brasil under Certificate of Presentation for Ethical Appreciation (CAAE) 59955722.3.0000.5364, report number 5,525,543. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist for case control studies was carefully observed^ 13 ^.
RESULTS
Of the 37 patients analyzed, 16 (43.2%) underwent ERCP followed by CCT and 21 (56.8%) underwent CCT followed by ERCP, both procedures in the same anesthetic/surgical procedure. Table 1 demonstrates the characteristics of the sample. The overall success rate in bile duct clearance was 75.7% and the rate of complications attributed to ERCP was 10.8%, corresponding to the four cases of post-ERCP pancreatitis. The Sugrue score was used to classify the observed difficulty during CCT and no case of extreme difficulty was identified (grade D), so that the majority of cases (48.6%) were considered easy to perform.
There was a complication in only one case, which required treatment, which characterizes grade II in the Clavien-Dindo classification^ 7 ^. The patient underwent ERCP first and subsequently required laparoscopic reapproach on the second postoperative day due to choleperitoneum of 530 mL, secondary to leakage in the cystic duct clipping. This patient was discharged on the eighth postoperative day after the initial procedure, without other complications.
Table 2 demonstrates that, although there was no randomization or even targeted allocation of patients between the "ERCP First" or "Cholecystectomy First" groups, most variables did not differ significantly between groups, demonstrating a certain homogeneity between them. There was a significant difference in the variables "amylase on arrival", which was higher in the group undergoing CCT first (p=0.008, p<0.05), and in the variable "bile duct cannulation success", which was significantly more successful in the "CCT first" group (p=0.020, p<0.05), this relationship being statistically confirmed by residue analysis and Cramer's V test (p=0.038, p<0.05).
Regarding the success in clearance of the bile duct, Table 3 demonstrates that younger ages, presence of stones in the distal common bile duct and shorter time duration of the procedure were factors statistically associated with successful bile duct clearance. Lymphopenia and cholecystitis as an initial presentation, in turn, were associated with failure in the bile duct clearance. There was no significant difference in the other variables studied.
DISCUSSION
The study presents a series of cases of cholelithiasis associated with choledocholithiasis, treated with ERCP and CCT in a single act. The overall rate of success in bile duct cannulation was 91.9%, bile duct clearance of 75.7%, post-ERCP pancreatitis of 10.8%, all data remaining within the scope defined in global literature^ 1,3-5,9,13,19,20,24,34 ^. This data corroborates the safety and effectiveness of the procedures, already suggested by other previously published articles^ 12-14,18,20,33,39 ^.
The evaluation of success rates and complications when comparing patients who underwent ERCP first or CCT first, in the same surgical/anesthetic act, demonstrated that there was a significant association between performing cholecystectomy first and successful cannulation of the bile duct. There was no difference between the groups when evaluating difficulty in performance of cholecystectomy, the rate of post-ERCP pancreatitis and success in bile duct clearance^ 39 ^.
These findings oppose the empiricism that performing ERCP first would make subsequent CCT difficult due to gaseous distension of the digestive tract, as well as that CCT first could be associated with biliary fistulas due to increased pressure caused by ERCP in the newly clipped cystic duct.
The technical steps to be observed in carrying out safe CCT, widely disseminated by Strasberg et al.^ 36 ^, culminated in the development of CCT intraoperative difficulty grading systems such as Sugrue et al.^ 37 ^. Although not all patients presented acute cholecystitis, the authors considered this score adequate to assess the technical difficulty in CCT and check its association with ERCP first.
Unlike other cases, the technique of laparoendoscopic rendezvous was not used in this series. This technique consists of performing CCT first with laparoscopic passage of a guidewire through the cystic duct towards the duodenum, running through the common bile duct and protruding through the major papilla. At this time, ERCP is performed by endoscopically identifying a guidewire and guided cannulation of the bile duct. This technique virtually eliminates the failure of bile duct catheterization, as well as the occurrence of post-ERCP pancreatitis^ 12,26,32,33 ^.
By demonstrating similar outcomes despite the order adopted, this study may serve to recommend performing ERCP first, because if failure of catheterization of the bile duct occurs using this, then CCT with retrograde catheterization of the cystic duct can be performed through laparoendoscopic rendezvous technique, allowing ERCP to be performed. If there is still a failure in the catheterization or bile duct clearance, there remains the option to laparoscopically explore the main bile duct. In cases of intraoperative diagnosis of choledocholithiasis using transcystic cholangiography during CCT, the option of laparoendoscopic rendezvous technique could also be used, increasing the success rate of ERCP. These statements, however, require confirmation by new, prospective and randomized studies.
CONCLUSIONS
This research did not reveal a significant difference in terms of complications and success in bile duct clearance among patients undergoing CCT and ERCP in the same surgical/anesthetic procedure, regardless of which procedure was performed first. A higher success rate was registered in bile duct cannulation in patients undergoing CCT first. Lymphopenia and cholecystitis were associated with failure in bile duct clearance.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Al-Mansour MR Fung EC Jones EL Zayan NE Wetzel TD Martin Del Campo SE Surgeon-performed endoscopic retrograde cholangiopancreatography. Outcomes of 2392 procedures at two tertiary care centers Surg Endosc 20183262871287610.1007/s 00464-017-5995-x 29273876 PMC 5957783 · doi ↗ · pubmed ↗
- 2Alves JR Klock DM Ronzani FG Santos SL Amico EC. Asymptomatic cholelithiasis: expectant or cholecystectomy. A systematic review Arq Bras Cir Dig 202336 e 174710.1590/0102-672020230029 e 174737466567 PMC 10355999 · doi ↗ · pubmed ↗
- 3Atamanalp SS Yildirgan MI Kantarci A. Endoscopic retrograde cholangiopancreatography (ERCP): outcomes of 3136 cases over 10 years Turkish Journal of Medical Sciences 201141461562110.3906/sag-1008-1088 · doi ↗
- 4Borges AC Almeida PC Furlani SMT Cury MS Pleskow DK. ERCP performance in a tertiary brazilian center: focus on new risk factors, complications and quality indicators Arq Bras Cir Dig 2018311 e 134810.1590/0102-672020180001 e 134829947682 PMC 6049994 · doi ↗ · pubmed ↗
- 5Choi JH Kim HJ Lee BU Kim TH Song IH. Vigorous periprocedural hydration with lactated ringer's solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients Clin Gastroenterol Hepatol 201715186.e 192.e 110.1016/j.cgh.2016.06.00727311618 · doi ↗ · pubmed ↗
- 6Choksi NS Fogel EL Cote GA Romagnuolo J Elta GH Scheiman JM The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement Gastrointest Endosc 201581115015510.1016/j.gie.2014.07.03325527053 · doi ↗ · pubmed ↗
- 7Clavien PA Baillie J. Diseases of the gallbladder and bile ducts: diagnosis and treatment Philadelphia John Wiley & Sons 2008
- 8Coelho JCU Costa MAR Enne M Torres OJM Andraus W Campos ACL. Acute cholecystitis in high-risk patients. Surgical, radiological, or endoscopic treatment? Brazilian college of digestive surgery position paper Arq Bras Cir Dig 202336 e 174910.1590/0102-672020230031 e 174937729280 PMC 10510100 · doi ↗ · pubmed ↗
